Yu-Waye Chu
CIK 1854586 · Chief Medical Officer · last filed 2026-03-19
Yu-Waye Chu is a Chief Medical Officer who has filed 16 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $136.7K of CTMX on Mar 19, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $860.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$860.0K
2
16
-$1.19M
Holdings By Company
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-19 | CTMX | Sell (S) | −21,279 | -$136.7K | EDGAR |
| 2026-02-04 | CTMX | Grant (A) | +75,000 | $0 | EDGAR |
| 2025-09-30 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2025-03-20 | CTMX | Sell (S) | −4,025 | -$2.4K | EDGAR |
| 2025-02-06 | CTMX | Grant (A) | +113,500 | $0 | EDGAR |
| 2024-01-19 | CTMX | Grant (A) | +26,250 | $0 | EDGAR |
| 2023-07-20 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2023-04-19 | FATE | Sell (S) | −2,532 | -$16.6K | EDGAR |
| 2023-02-07 | FATE | Grant (A) | — | $0 | EDGAR |
| 2023-01-11 | FATE | Sell (S) | −7,825 | -$41.0K | EDGAR |